Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

CORRECTING and REPLACING Anika to Issue Fourth-Quarter and Full-Year 2019 Financial Results and Business Highlights on Thursday, February 20


First paragraph, first sentence should read: Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its fourth-quarter and full-year 2019 financial results after the close of the market on Thursday, February 20, 2020 and hold its investor conference call on the same day, Thursday, February 20, 2020, at 5:00 p.m. ET to discuss its financial results, business highlights, and outlook.

The corrected release reads:

ANIKA TO ISSUE FOURTH-QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS ON THURSDAY, FEBRUARY 20

Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its fourth-quarter and full-year 2019 financial results after the close of the market on Thursday, February 20, 2020 and hold its investor conference call on the same day, Thursday, February 20, 2020, at 5:00 p.m. ET to discuss its financial results, business highlights, and outlook.

The conference call can be accessed by dialing 1-855-468-0611 (toll-free domestic) or 1-484-756-4332 (international). A live audio webcast will be available in the "Investor Relations" section of Anika's website, www.anikatherapeutics.com. An accompanying slide presentation also can be accessed via the Anika Therapeutics website. The call will be archived and accessible on the same website shortly after its conclusion.

About Anika Therapeutics, Inc.

Anika Therapeutics, Inc. (NASDAQ: ANIK) is a global, integrated joint preservation and regenerative therapies company based in Bedford, Mass. Anika is committed to delivering therapies to improve the lives of patients across a continuum of care from osteoarthritis pain management to joint preservation and restoration. The company has more than two decades of global expertise commercializing more than 20 products based on its proprietary hyaluronic acid (HA) technology platform. For more information about Anika, please visit www.anikatherapeutics.com.


These press releases may also interest you

at 06:05
Spotify Technology S.A. has released its financial results for the first quarter of 2024 today. Please visit investors.spotify.com to view the Shareholder Deck and other supplemental materials. As previously announced, the company will host a live...

at 06:05
FREYR Battery ("FREYR"), a developer of next-generation battery cell production capacity, will publish a press release detailing first quarter 2024 results and conduct a conference call on May 8, 2024. The first quarter 2024 press release will be...

at 06:05
UPS today announced first-quarter 2024 consolidated revenues of $21.7 billion, a 5.3% decrease from the first quarter of 2023. Consolidated operating profit was $1.6 billion, down 36.5% compared to the first quarter of 2023, and down 31.5% on an...

at 06:05
Banc of California, Inc. : $0.17 Earnings Per Share $0.19 Adjusted Earnings Per Share(1) $17.18 Book Value Per Share $15.07 Tangible Book Value Per Share(1) 10.12% CET1 Ratio 27% Noninterest-Bearing Deposits...

at 06:00
Madison Street Capital (MSC), an international investment banking firm, acted as the exclusive advisor in the sale of Cenergy International Services, Inc. ("Cenergy") to First Tek, Inc. ("First Tek"). Founded in 1996 and headquartered in Houston,...

at 06:00
Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) , a leading global solar project developer, owner, and operator, today announced the successful co-development agreement of 199 MW (up to 1.59GWh of capacity) of Battery Storage Projects...



News published on and distributed by: